文献速递瓣膜外科主动脉外科

经导管主动脉瓣置换术外科取出术死亡率的医院容量-结局关系

Volume-outcome relationship of mortality following surgical explant of transcatheter aortic valve replacements.
PubMed 文献 · J Thorac Cardiovasc Surg · 2025-10-13

低容量医院合并手术死亡率显著高于孤立手术,高容量医院无此差异。近期数据提示容量-结局关系消失,TAVR取出术将成心脏外科基本手术。

要点

  • 早期低容量医院TAVR取出术30天死亡率更高,近期该差异消失。
  • 低容量医院合并TAVR取出术死亡率显著高于孤立手术。
  • 高容量医院可能更适合处理高危合并手术。

核心结论

  • 早期存在医院容量与TAVR取出术死亡率的负相关,但近期数据未显示容量-结局关系。
  • 低容量医院中合并TAVR取出术的30天和1年死亡率均高于孤立手术。
  • 高容量医院中合并与孤立TAVR取出术的死亡率无显著差异。

研究设计与样本

  • 回顾性队列研究,查询2016至2024年Center for Medicare & Medicaid Services数据库。
  • 共纳入123例TAVR取出术患者,研究期分为早期(2016-2021)和近期(2022-2024)。
  • 医院按容量分为低容量和高容量组,比较30天和1年死亡率并做多因素分析。

主要发现

  • 375家医院中235家(63%)实施少于3例TAVR取出术。
  • 总体术后30天死亡率为13.3%,1年死亡率为18.3%。

关键数值与推荐

  • 高容量医院状态在早期与较低死亡率相关(OR 0.48;95%CI 0.25-0.95)。
  • 近期高容量医院状态与死亡率无关(OR 1.30;95%CI 0.71-2.38)。
  • 总队列中高容量医院状态与死亡率无关(OR 0.80;95%CI 0.51-1.24)。

临床怎么用

  • TAVR取出术正成为心脏外科基本手术,不应仅依赖医院容量选择中心。
  • 低容量医院应谨慎评估合并手术风险,高危患者可考虑转诊至高容量医院。

局限性

  • 样本量较小(123例),可能影响统计效能。
  • 基于行政数据库,可能存在编码偏倚和未测量混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the relationship between hospital volume of transcatheter aortic valve replacement (TAVR) explants and postoperative mortality. METHODS: The Center for Medicare & Medicaid Services was queried from 2016 to 2024 for patients who underwent TAVR explant. The study period was divided into 2 eras: early (2016-2021) and recent (2022-2024). Hospitals were classified grouped as low volume or high volume. Both 30-day and 1-year mortality were compared, and multivariable analysis was performed. RESULTS: We identified a total of 123 TAVR explants during the study period. Of the 375 hospitals that performed at least 1 TAVR explant, 235 (63%) performed fewer than 3 explants. Postoperative mortality was 13.3% at 30 days and 18.3% at 1 year. Thirty-day mortality was higher in low-volume hospitals compared to high-volume hospitals in the early era (17% vs 9.68%; P = .029), but not in the recent era (11.0% vs 13.4%; P = .409). At low-volume hospitals, both 30-day and 1-year mortality were higher following concomitant TAVR explant compared to isolated TAVR explant (19.9% vs 9.3% [P < .001] and 25.4% vs 13.6% [P < .001], respectively), but not in high-volume hospitals (14% vs 8.78% [P = .148] and 18.3% vs 15.5% [P = .518], respectively). On multivariable analysis, high-volume hospital status was associated with lower mortality for the early era (odds ratio [OR], 0.48; 95% confidence interval [CI], 0.25-0.95), but not for the recent era (OR, 1.30; 95% CI, 0.71-2.38) or the total cohort (OR, 0.80; 95% CI, 0.51-1.24). CONCLUSIONS: While a hospital volume-outcome relationship to TAVR explant mortality existed in the early era, recent data suggest no volume-outcome relationship. With the lack of a volume-outcome relationship, TAVR explant will become a fundamental cardiac surgical procedure. High-risk concomitant surgery may benefit from high-volume hospital management.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Braasch MC, Rahimi M, He J, et al. Volume-outcome relationship of mortality following surgical explant of transcatheter aortic valve replacements. J Thorac Cardiovasc Surg. 2025. PMID: 41093006. doi:10.1016/j.jtcvs.2025.09.053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。